{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T05:02:51Z","timestamp":1780117371584,"version":"3.54.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100002973","name":"Daiichi Sankyo Korea Co., Ltd.","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s12325-026-03573-9","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T08:04:37Z","timestamp":1774944277000},"page":"2593-2610","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-Pill Combination Olmesartan\/Amlodipine\/Hydrochlorothiazide Safety and Effectiveness in Older Patients with Hypertension: Pooled Analysis of Post-Approval Observational Studies"],"prefix":"10.1007","volume":"43","clinical-trial-number":[{"clinical-trial-number":"kct0010343","registry":"10.18810\/cris"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7885-1695","authenticated-orcid":false,"given":"Hyun-Jin","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-6690","authenticated-orcid":false,"given":"Hyue Mee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-4871","authenticated-orcid":false,"given":"Dae-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"3573_CR1","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/s41569-021-00559-8","volume":"18","author":"B Zhou","year":"2021","unstructured":"Zhou B, Perel P, Mensah GA, Ezzati M. Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension. Nat Rev Cardiol. 2021;18:785\u2013802.","journal-title":"Nat Rev Cardiol"},{"key":"3573_CR2","unstructured":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45:3912\u20134018."},{"issue":"1","key":"3573_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-023-00234-9","volume":"29","author":"HL Kim","year":"2023","unstructured":"Kim HL, Lee EM, Ahn SY, et al. The 2022 focused update of the 2018 Korean Hypertension Society Guidelines for the management of hypertension. Clinical Hypertension. 2023;29(1):11.","journal-title":"Clinical Hypertension"},{"key":"3573_CR4","unstructured":"2024 ESH clinical practice guidelines for the management of arterial hypertension. Eur J Int Med. 2024;126:1\u201315."},{"key":"3573_CR5","doi-asserted-by":"crossref","unstructured":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017;71(6):1269\u20131324.","DOI":"10.1161\/HYP.0000000000000066"},{"key":"3573_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.7326\/0003-4819-121-5-199409010-00008","volume":"121","author":"JT Insua","year":"1994","unstructured":"Insua JT, Sacks HS, Lau TS, et al. Drug treatment of hypertension in the elderly: a meta-analysis. Ann Intern Med. 1994;121:355\u201362.","journal-title":"Ann Intern Med"},{"key":"3573_CR7","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1136\/bmj.39548.738368.BE","volume":"336","author":"F Turnbull","year":"2008","unstructured":"Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121\u20133.","journal-title":"BMJ"},{"key":"3573_CR8","first-page":"225","volume":"38","author":"TD Wang","year":"2022","unstructured":"Wang TD, Chiang CE, Chao TH, et al. 2022 Guidelines of the Taiwan society of cardiology and the Taiwan hypertension society for the management of hypertension. Acta Cardiol Sin. 2022;38:225\u2013325.","journal-title":"Acta Cardiol Sin"},{"key":"3573_CR9","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/ajh\/hpad039","volume":"36","author":"MF Cheema","year":"2023","unstructured":"Cheema MF, Butt Z, Gilani S, et al. Intensive blood pressure control and cardiovascular outcomes in elderly patients: a secondary analysis of SPRINT study based on a 60-year age cutoff. Am J Hypertens. 2023;36:491\u20137.","journal-title":"Am J Hypertens"},{"key":"3573_CR10","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1056\/NEJMoa2111437","volume":"385","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang S, Deng Y, et al. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med. 2021;385:1268\u201379.","journal-title":"N Engl J Med"},{"key":"3573_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1751-7176.2011.00588.x","volume":"14","author":"DJ Kereiakes","year":"2012","unstructured":"Kereiakes DJ, Chrysant SG, Izzo JL, et al. Long-term efficacy and safety of triple-combination therapy with olmesartan medoxomil and amlodipine besylate and hydrochlorothiazide for hypertension. J Clin Hypertens (Greenwich). 2012;14:149\u201357.","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"4","key":"3573_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004223","volume":"20","author":"JP Sheppard","year":"2023","unstructured":"Sheppard JP, Koshiaris C, Stevens R, et al. The association between antihypertensive treatment and serious adverse events by age and frailty: a cohort study. PLoS Med. 2023;20(4):e1004223.","journal-title":"PLoS Med"},{"key":"3573_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n189","volume":"372","author":"A Albasri","year":"2021","unstructured":"Albasri A, Hattle M, Koshiaris C, et al. Association between antihypertensive treatment and adverse events: systematic review and meta-analysis. BMJ. 2021;372:n189.","journal-title":"BMJ"},{"key":"3573_CR14","volume":"48","author":"J Wiersinga","year":"2025","unstructured":"Wiersinga J, Jansen S, Peters MJL, et al. Hypertension and orthostatic hypotension in the elderly: a challenging balance. Lancet. 2025;48:101154.","journal-title":"Lancet"},{"key":"3573_CR15","doi-asserted-by":"publisher","DOI":"10.5646\/ch.2025.31.e11","volume":"31","author":"HC Kim","year":"2025","unstructured":"Kim HC, Lee H, Lee HH, et al. Korea Hypertension Fact Sheet 2024: nationwide population-based analysis with a focus on young adults. Clin Hypertens. 2025;31:e11.","journal-title":"Clin Hypertens"},{"issue":"1","key":"3573_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1177\/1753944713520062","volume":"8","author":"HA Punzi","year":"2014","unstructured":"Punzi HA. Efficacy and safety of olmesartan\/amlodipine\/hydrochlorothiazide in patients with hypertension not at goal with mono, dual or triple drug therapy: results of the CHAMPiOn study. Ther Adv Cardiovasc Dis. 2014;8(1):12\u201321.","journal-title":"Ther Adv Cardiovasc Dis"},{"issue":"4","key":"3573_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/BF03261832","volume":"12","author":"SG Chrysant","year":"2012","unstructured":"Chrysant SG, Littlejohn T, Izzo JL, et al. Triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in black and non-black study participants with hypertension: the TRINITY randomized, double-blind, 12-week, parallel-group study. Am J Cardiovasc Drugs. 2012;12(4):233\u201343.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"8","key":"3573_CR18","doi-asserted-by":"publisher","first-page":"3500","DOI":"10.1007\/s12325-020-01404-z","volume":"37","author":"S-J Park","year":"2020","unstructured":"Park S-J, Rhee SJ. Real-world effectiveness and safety of a single-pill combination of olmesartan\/amlodipine\/hydrochlorothiazide in Korean patients with essential hypertension (RESOLVE): a large, observational, retrospective, cohort study. Adv Ther. 2020;37(8):3500\u201314.","journal-title":"Adv Ther"},{"key":"3573_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s40885-021-00177-z","volume":"27","author":"IS Sohn","year":"2021","unstructured":"Sohn IS, Ihm S-H, Kim GH, et al. Real-world evidence on the strategy of olmesartan-based triple single-pill combination in Korean hypertensive patients: a prospective, multicenter, observational study (RESOLVE-PRO). Clin Hypertens. 2021;27:21.","journal-title":"Clin Hypertens"},{"key":"3573_CR20","doi-asserted-by":"publisher","first-page":"4817","DOI":"10.1007\/s12325-023-02632-9","volume":"40","author":"J Oh","year":"2023","unstructured":"Oh J, Kim W, Kim G-H, et al. Real-world effectiveness and safety of a single-pill combination of olmesartan\/amlodipine\/hydrochlorothiazide in Korean patients with hypertension and cardiovascular risk factors. Adv Ther. 2023;40:4817\u201335.","journal-title":"Adv Ther"},{"key":"3573_CR21","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40885-023-00243-8","volume":"29","author":"HC Kim","year":"2023","unstructured":"Kim HC, Lee H, Lee H-H, et al. Korea hypertension fact sheet 2022: analysis of nationwide population-based data with a special focus on hypertension in the elderly. Clin Hypertens. 2023;29:22.","journal-title":"Clin Hypertens"},{"key":"3573_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-024-00262-z","volume":"30","author":"HC Kim","year":"2024","unstructured":"Kim HC, Lee H, Lee HH, et al. Korea hypertension fact sheet 2023: analysis of nationwide population\u2011based data with a particular focus on hypertension in special populations. Clinical Hypertension. 2024;30:7.","journal-title":"Clinical Hypertension"},{"issue":"3","key":"3573_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/HYPERTENSIONAHA.119.14309","volume":"75","author":"S Juraschek","year":"2020","unstructured":"Juraschek S, Taylor A, Wright J, et al. Orthostatic hypotension, cardiovascular outcomes, and adverse events: results from SPRINT. Hypertension. 2020;75(3):660\u20137.","journal-title":"Hypertension"},{"issue":"24","key":"3573_CR24","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u226575 years. JAMA. 2016;315(24):2673\u201382.","journal-title":"JAMA"},{"issue":"6","key":"3573_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.7326\/M16-1754","volume":"166","author":"J Weiss","year":"2017","unstructured":"Weiss J, Freeman M, Low A, et al. Benefits and harms of intensive blood pressure treatment in adults aged 60 years or older: a systematic review and meta-analysis. Ann Intern Med. 2017;166(6):419\u201329.","journal-title":"Ann Intern Med"},{"issue":"8","key":"3573_CR26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/00004872-199608000-00003","volume":"14","author":"H Vanhanen","year":"1996","unstructured":"Vanhanen H, Thijs L, Birkenh\u00e4ger W, et al. Associations of orthostatic blood pressure fall in older patients with isolated systolic hypertension. J Hypertens. 1996;14(8):943\u20139.","journal-title":"J Hypertens"},{"key":"3573_CR27","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1001\/jamainternmed.2017.2924","volume":"177","author":"JD Sexton","year":"2017","unstructured":"Sexton JD, Canney MC, O\u2019Connell MDL, et al. Injurious falls and syncope in older community-dwelling adults meeting inclusion criteria for SPRINT. JAMA Intern Med. 2017;177:1385\u20137.","journal-title":"JAMA Intern Med"},{"key":"3573_CR28","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1111\/cts.12979","volume":"14","author":"J Sung","year":"2021","unstructured":"Sung J, Ahn KT, Cho B-R, et al. Adherence to triple-component antihypertensive regimens is higher with single-pill than equivalent two-pill regimens: a randomized controlled trial. Clin Transl Sci. 2021;14:1185\u201392.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"3573_CR29","first-page":"11","volume":"11","author":"L Teng","year":"2023","unstructured":"Teng L, Wang D, Zhou Z, et al. Associations among frailty status, hypertension, and fall risk in community-dwelling older adults. Int J Nurs Sci. 2023;11(1):11\u20137.","journal-title":"Int J Nurs Sci"},{"key":"3573_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.3904\/kjim.2019.196","volume":"34","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kim K-I, Cho M-C. Current status and therapeutic considerations of hypertension in the elderly. Korean J Intern Med. 2019;34:687\u201395.","journal-title":"Korean J Intern Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12325-026-03573-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-026-03573-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T04:51:12Z","timestamp":1780116672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12325-026-03573-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["3573"],"URL":"https:\/\/doi.org\/10.1007\/s12325-026-03573-9","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Hyun-Jin Kim and Hyue Mee Kim declare that they have no competing interests. Dae-Hee Kim has received honoraria from Viatris, Organon, Boryoung, Hanmi, Daewoong, Celltrion, Daiichi Sankyo, and Chong Kun Dang, and a research grant from Daewoong.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study protocol was approved by the Institutional Review Board of Asan Medical Center, Seoul, Republic of Korea (IRB no. 2024\u20130503) and was conducted in accordance with the principles of the Declaration of Helsinki 1964 and its later amendments, as well as the rules of the IRB. All patients voluntarily provided written informed consent before enrolling in the study. Study data were de-identified to protect the privacy of the participating patients and to comply with locally applicable regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}